Immunotherapeutic strategies for hepatocellular carcinoma

Gastroenterology

Volumn 127, Issue 5 SUPPL., 2004, Pages

  Butterfield, Lisa H ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADJUVANT; ALPHA FETOPROTEIN; ANTINEOPLASTIC AGENT; BCG VACCINE; CD40 LIGAND; CYTOKINE; DNA VACCINE; DOXORUBICIN; FLT3 LIGAND; GAMMA INTERFERON; GENE PRODUCT; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 12; INTERLEUKIN 2; INTERLEUKIN 4; KEYHOLE LIMPET HEMOCYANIN; PLASMID DNA; TUMOR ANTIGEN; TUMOR NECROSIS FACTOR ALPHA; TUMOR VACCINE; VIRUS ANTIGEN;

ADENOVIRUS; ADOPTIVE TRANSFER; ANTIGEN PRESENTING CELL; ANTIGEN SPECIFICITY; CANCER IMMUNIZATION; CANCER IMMUNOTHERAPY; CANCER RECURRENCE; CANCER SURVIVAL; CELL LYSATE; CLINICAL TRIAL; COLORECTAL CANCER; CONFERENCE PAPER; CYTOTOXIC LYMPHOCYTE; DENDRITIC CELL; DRUG EFFECT; GENE TARGETING; GENE VECTOR; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; IMMUNE RESPONSE; LIVER CELL CARCINOMA; LIVER METASTASIS; LYMPHOCYTE TRANSFER; LYMPHOKINE ACTIVATED KILLER CELL; MUTATION; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; TUMOR ASSOCIATED LEUKOCYTE; TUMOR CELL;

EID: 7044226216     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2004.09.038     Document Type: Conference Paper

References (46)

1. G. Luo, S. Huang, X. Xie, E. Stockert, Y.T. Chen, B. Kubuschok, M. Pfreundschuh Expression of cancer-testis genes in human hepatocellular carcinomas Cancer Immun 2 2002 11
2. H.S. Chen, L.L. Qin, X. Cong, Y. Wang, R. Fei, D. Jiang, J. Cao, J.J. Su, L. Wei, W.F. Chen [Expression of tumor-specific cancer/testis antigens in hepatocellular carcinoma] Zhonghua Gan Zang Bing Za Zhi 11 2003 145 148
3. N. Yamashita, H. Ishibashi, K. Hayashida, J. Kudo, K. Takenaka, K. Itoh, Y. Niho High frequency of the MAGE-1 gene expression in hepatocellular carcinoma Hepatology 24 1996 1437 1440
4. K. Kariyama, T. Higashi, Y. Kobayashi, K. Nouso, H. Nakatsukasa, T. Yamano, M. Ishizaki, T. Kaneyoshi, N. Toshikuni, T. Ohnishi, K. Fujiwara, E. Nakayama, L. Terracciano, G.C. Spagnoli, T. Tsuji Expression of MAGE-1 and -3 genes and gene products in human hepatocellular carcinoma Br J Cancer 81 1999 1080 1087
5. K. Tahara, M. Mori, N. Sadanaga, Y. Sakamoto, S. Kitano, M. Makuuchi Expression of the MAGE gene family in human hepatocellular carcinoma Cancer 85 1999 1234 1240
6. C.H. Chen, G.J. Chen, H.S. Lee, G.T. Huang, P.M. Yang, L.J. Tsai, D.S. Chen, J.C. Sheu Expressions of cancer-testis antigens in human hepatocellular carcinomas Cancer Lett 164 2001 189 195
7. D.C. Mou, S.L. Cai, J.R. Peng, Y. Wang, H.S. Chen, X.W. Pang, X.S. Leng, W.F. Chen Evaluation of MAGE-1 and MAGE-3 as tumour-specific markers to detect blood dissemination of hepatocellular carcinoma cells Br J Cancer 86 2002 110 116
8. A. Zerbini, M. Pilli, P. Soliani, S. Ziegler, G. Pelosi, A. Orlandini, C. Cavallo, J. Uggeri, R. Scandroglio, P. Crafa, G.C. Spagnoli, C. Ferrari, G. Missale Ex vivo characterization of tumor-derived melanoma antigen encoding gene-specific CD8+ cells in patients with hepatocellular carcinoma J Hepatol 40 2004 102 109
9. N. Iizuka, M. Oka, H. Yamada-Okabe, N. Mori, T. Tamesa, T. Okada, N. Takemoto, A. Tangoku, K. Hamada, H. Nakayama, T. Miyamoto, S. Uchimura, Y. Hamamoto Comparison of gene expression profiles between hepatitis B virus- and hepatitis C virus-infected hepatocellular carcinoma by oligonucleotide microarray data on the basis of a supervised learning method Cancer Res 62 2002 3939 3944
10. Y. Wang, K.J. Han, X.W. Pang, H.A. Vaughan, W. Qu, X.Y. Dong, J.R. Peng, H.T. Zhao, J.A. Rui, X.S. Leng, J. Cebon, A.W. Burgess, W.F. Chen Large scale identification of human hepatocellular carcinoma-associated antigens by autoantibodies J Immunol 169 2002 1102 1109
11. T. Kato, S. Satoh, H. Okabe, O. Kitahara, K. Ono, C. Kihara, T. Tanaka, T. Tsunoda, Y. Yamaoka, Y. Nakamura, Y. Furukawa Isolation of a novel human gene, MARKL1, homologous to MARK3 and its involvement in hepatocellular carcinogenesis Neoplasia 3 2001 4 9
12. H. Okabe, S. Satoh, T. Kato, O. Kitahara, R. Yanagawa, Y. Yamaoka, T. Tsunoda, Y. Furukawa, Y. Nakamura Genome-wide analysis of gene expression in human hepatocellular carcinomas using cDNA microarray identification of genes involved in viral carcinogenesis and tumor progression Cancer Res 61 2001 2129 2137
13. S.T. Cheung, X. Chen, X.Y. Guan, S.Y. Wong, L.S. Tai, I.O. Ng, S. So, S.T. Fan Identify metastasis-associated genes in hepatocellular carcinoma through clonality delineation for multinodular tumor Cancer Res 62 2002 4711 4721
14. N.A. Habib, S.F. Ding, R. el-Masry, R.R. Mitry, K. Honda, N.E. Michail, G. Dalla Serra, G. Izzi, L. Greco, M. Bassyouni, M. el-Toukhy, Y. Abdel-Gaffar Preliminary report the short-term effects of direct p53 DNA injection in primary hepatocellular carcinomas Cancer Detect Prev 20 1996 103 107
15. S.Y. Lu, Y.F. Sui, Z.S. Li, J. Ye, H.L. Dong, P. Qu, X.M. Zhang, W.Y. Wang, Y.S. Li Superantigen-SEA gene modified tumor vaccine for hepatocellular carcinoma an in vitro study World J Gastroenterol 10 2004 53 57
16. G. Schueller, A. Stift, J. Friedl, P. Dubsky, T. Bachleitner-Hofmann, T. Benkoe, R. Jakesz, M. Gnant Hyperthermia improves cellular immune response to human hepatocellular carcinoma subsequent to co-culture with tumor lysate pulsed dendritic cells Int J Oncol 22 2003 1397 1402
17. J. Banchereau, R.M. Steinman Dendritic cells and the control of immunity Nature 392 1998 245 252
18. S. Beckebaum, V.R. Cicinnati, G. Dworacki, J. Muller-Berghaus, D. Stolz, J. Harnaha, T.L. Whiteside, A.W. Thomson, L. Lu, J.J. Fung, C.A. Bonham Reduction in the circulating pDC1/pDC2 ratio and impaired function of ex vivo-generated DC1 in chronic hepatitis B infection Clin Immunol 104 2002 138 150
19. T. Ninomiya, S.M. Akbar, T. Masumoto, N. Horiike, M. Onji Dendritic cells with immature phenotype and defective function in the peripheral blood from patients with hepatocellular carcinoma J Hepatol 31 1999 323 331
20. S. Takagi, K. Chen, R. Schwarz, S. Iwatsuki, R.B. Herberman, T.L. Whiteside Functional and phenotypic analysis of tumor-infiltrating lymphocytes isolated from human primary and metastatic liver tumors and cultured in recombinant interleukin-2 Cancer 63 1989 102 111
21. P. Hanke, C. Rabe, M. Serwe, S. Bohm, C. Pagenstecher, T. Sauerbruch, W.H. Caselmann Cirrhotic patients with or without hepatocellular carcinoma harbour AFP-specific T-lymphocytes that can be activated in vitro by human alpha-fetoprotein Scand J Gastroenterol 37 2002 949 955
22. L.H. Butterfield, A. Ribas, W.S. Meng, V.B. Dissette, S. Amarnani, H.T. Vu, E. Seja, K. Todd, J.A. Glaspy, W.H. McBride, J.S. Economou T-cell responses to HLA-A2.1 immunodominant peptides derived from alpha-fetoprotein in patients with hepatocellular cancer Clin Cancer Res 9 2003 5902 5908
23. K. Yanagi, Y. Nagayama, K. Nakao, A. Saeki, K. Matsumoto, T. Ichikawa, H. Ishikawa, K. Hamasaki, N. Ishii, K. Eguchi Immuno-gene therapy with adenoviruses expressing fms-like tyrosine kinase 3 ligand and CD40 ligand for mouse hepatoma cells in vivo Int J Oncol 22 2003 345 351
24. J.F. Arthur, L.H. Butterfield, M.D. Roth, L.A. Bui, S.M. Kiertscher, R. Lau, S. Dubinett, J. Glaspy, W.H. McBride, J.S. Economou A comparison of gene transfer methods in human dendritic cells Cancer Gene Ther 4 1997 17 25
25. Y. Guo, M. Wu, H. Chen, X. Wang, G. Liu, G. Li, J. Ma, M.S. Sy Effective tumor vaccine generated by fusion of hepatoma cells with activated B cells Science 263 1994 518 520
26. S. Homma, G. Toda, J. Gong, D. Kufe, T. Ohno Preventive antitumor activity against hepatocellular carcinoma (HCC) induced by immunization with fusions of dendritic cells and HCC cells in mice J Gastroenterol 36 2001 764 771
27. W.C. Lee, H.C. Wang, L.B. Jeng, Y.J. Chiang, C.R. Lia, P.F. Huang, M.F. Chen, S. Qian, L. Lu Effective treatment of small murine hepatocellular carcinoma by dendritic cells Hepatology 34 2001 896 905
28. T. Tatsumi, T. Takehara, T. Kanto, T. Miyagi, N. Kuzushita, Y. Sugimoto, M. Jinushi, A. Kasahara, Y. Sasaki, M. Hori, N. Hayashi Administration of interleukin-12 enhances the therapeutic efficacy of dendritic cell-based tumor vaccines in mouse hepatocellular carcinoma Cancer Res 61 2001 7563 7567
29. N.J. Lygidakis, P. Kosmidis, N. Ziras, J. Parissis, E. Kyparidou Combined transarterial targeting locoregional immunotherapy-chemotherapy for patients with unresectable hepatocellular carcinoma a new alternative for an old problem J Interferon Cytokine Res 15 1995 467 472
30. W. Reinisch, M. Holub, A. Katz, A. Herneth, C. Lichtenberger, M. Schoniger-Hekele, T. Waldhoer, G. Oberhuber, P. Ferenci, A. Gangl, C. Mueller Prospective pilot study of recombinant granulocyte-macrophage colony-stimulating factor and interferon-gamma in patients with inoperable hepatocellular carcinoma J Immunother 25 2002 489 499
31. Y. Une, A. Kawata, J. Uchino [Adopted immunochemotherapy using IL-2 and spleen LAK cell--randomized study] Nippon Geka Gakkai Zasshi 92 1991 1330 1333
32. A. Kawata, Y. Une, M. Hosokawa, Y. Wakizaka, T. Namieno, J. Uchino, H. Kobayashi Adjuvant chemoimmunotherapy for hepatocellular carcinoma patients. Adriamycin, interleukin-2, and lymphokine-activated killer cells versus Adriamycin alone Am J Clin Oncol 18 1995 257 262
33. T. Takayama, M. Makuuchi, T. Sekine, S. Terui, H. Shiraiwa, T. Kosuge, S. Yamazaki, H. Hasegawa, K. Suzuki, M. Yamagata, M. Fujii, T. Tanaka, T. Kakizoe Distribution and therapeutic effect of intraarterially transferred tumor-infiltrating lymphocytes in hepatic malignancies. A preliminary report Cancer 68 1991 2391 2396
34. Y. Wang, H. Chen, M. Wu, J. Bao, W. Cong, H. Wang Postoperative immunotherapy for patients with hepatocarcinoma using tumor-infiltrating lymphocytes Chin Med J (Engl) 110 1997 114 117
35. T. Takayama, T. Sekine, M. Makuuchi, S. Yamasaki, T. Kosuge, J. Yamamoto, K. Shimada, M. Sakamoto, S. Hirohashi, Y. Ohashi, T. Kakizoe Adoptive immunotherapy to lower postsurgical recurrence rates of hepatocellular carcinoma a randomised trial Lancet 356 2000 802 807
36. A. Ladhams, C. Schmidt, G. Sing, L. Butterworth, G. Fielding, P. Tesar, R. Strong, B. Leggett, L. Powell, G. Maddern, K. Ellem, G. Cooksley Treatment of non-resectable hepatocellular carcinoma with autologous tumor-pulsed dendritic cells J Gastroenterol Hepatol 17 2002 889 896
37. Y. Iwashita, K. Tahara, S. Goto, A. Sasaki, S. Kai, M. Seike, C.L. Chen, K. Kawano, S. Kitano A phase I study of autologous dendritic cell-based immunotherapy for patients with unresectable primary liver cancer Cancer Immunol Immunother 52 2003 155 161
38. A. Stift, J. Friedl, P. Dubsky, T. Bachleitner-Hofmann, G. Schueller, T. Zontsich, T. Benkoe, K. Radelbauer, C. Brostjan, R. Jakesz, M. Gnant Dendritic cell-based vaccination in solid cancer J Clin Oncol 21 2003 135 142
39. M. Kuang, B.G. Peng, M.D. Lu, L.J. Liang, J.F. Huang, Q. He, Y.P. Hua, S. Totsuka, S.Q. Liu, K.W. Leong, T. Ohno Phase II randomized trial of autologous formalin-fixed tumor vaccine for postsurgical recurrence of hepatocellular carcinoma Clin Cancer Res 10 2004 1574 1579
40. C.M. Vollmer Jr, F.C. Eilber, L.H. Butterfield, A. Ribas, V.B. Dissette, A. Koh, L.D. Montejo, M.C. Lee, K.J. Andrews, W.H. McBride, J.A. Glaspy, J.S. Economou Alpha-fetoprotein-specific genetic immunotherapy for hepatocellular carcinoma Cancer Res 59 1999 3064 3067
41. C.F. Grimm, D. Ortmann, L. Mohr, S. Michalak, T.U. Krohne, S. Meckel, S. Eislele, J. Encke, H.E. Blum, M. Geissler Mouse alpha-fetoprotein-specific DNA-based immunotherapy of hepatocellular carcinoma leads to tumor regression in mice Gastroenterology 119 2000 1104 1112
42. H.G. Rammensee, K. Falk, O. Rotzschke MHC molecules as peptide receptors Curr Opin Immunol 5 1993 35 44
43. L.H. Butterfield, A. Koh, W. Meng, C.M. Vollmer, A. Ribas, V. Dissette, E. Lee, J.A. Glaspy, W.H. McBride, J.S. Economou Generation of human T-cell responses to an HLA-A2.1-restricted peptide epitope derived from alpha-fetoprotein Cancer Res 59 1999 3134 3142
44. L.H. Butterfield, W.S. Meng, A. Koh, C.M. Vollmer, A. Ribas, V.B. Dissette, K. Faull, J.A. Glaspy, W.H. McBride, J.S. Economou T cell responses to HLA-A*0201-restricted peptides derived from human alpha fetoprotein J Immunol 166 2001 5300 5308
45. L.Y. Schumacher, A. Ribas, V.B. Dissette, J.A. Glaspy, W.H. McBride, J.S. Economou, L.H. Butterfield Human dendritic cell maturation by adenovirus transduction enhances tumor antigen-specific T cell responses J Immunother 27 2004 191 200
46. W.S. Meng, L.H. Butterfield, A. Ribas, V.B. Dissette, J.B. Heller, G.A. Miranda, J.A. Glaspy, W.H. McBride, J.S. Economou Alpha-fetoprotein-specific tumor immunity induced by plasmid prime-adenovirus boost genetic vaccination Cancer Res 61 2001 8782 8786